trying...
370884232023061920230619
1469-06912972023JulClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious DiseasesClin Microbiol InfectUpdate of European Society of Clinical Microbiology and Infectious Diseases coronavirus disease 2019 guidelines: diagnostic testing for severe acute respiratory syndrome coronavirus 2.876886876-88610.1016/j.cmi.2023.04.019S1198-743X(23)00192-1Since the onset of COVID-19, several assays have been deployed for the diagnosis of SARS-CoV-2. The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) published the first set of guidelines on SARS-CoV-2 in vitro diagnosis in February 2022. Because the COVID-19 landscape is rapidly evolving, the relevant ESCMID guidelines panel releases an update of the previously published recommendations on diagnostic testing for SARS-CoV-2. This update aims to delineate the best diagnostic approach for SARS-CoV-2 in different populations based on current evidence.An ESCMID COVID-19 guidelines task force was established by the ESCMID Executive Committee. A small group was established, half appointed by the chair, and the remaining selected with an open call. The panel met virtually once a week. For all decisions, a simple majority vote was used. A list of clinical questions using the population, intervention, comparison, and outcome (PICO) format was developed at the beginning of the process. For each PICO, 2 panel members performed a literature search focusing on systematic reviews with a third panellist involved in case of inconsistent results. The panel reassessed the PICOs previously defined as priority in the first set of guidelines and decided to address 49 PICO questions, because 6 of them were discarded as outdated/non-clinically relevant. The 'Grading of Recommendations Assessment, Development and Evaluation (GRADE)-adoption, adaptation, and de novo development of recommendations (ADOLOPMENT)' evidence-to-decision framework was used to produce the guidelines.After literature search, we updated 16 PICO questions; these PICOs address the use of antigen-based assays among symptomatic and asymptomatic patients with different ages, COVID-19 severity status or risk for severe COVID-19, time since the onset of symptoms/contact with an infectious case, and finally, types of biomaterials used.Copyright © 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.FragkouParaskevi CPCFirst Department of Critical Care Medicine & Pulmonary Services, Evangelismos General Hospital, National and Kapodistrian University of Athens, Athens, Greece; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Greece.De AngelisGiuliaGEuropean Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Greece; Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy.MenchinelliGiuliaGEuropean Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Greece; Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy; Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy.CanFusunFEuropean Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Greece; Department of Medical Microbiology, Koc University School of Medicine, Istanbul, Turkey; Koc University IsBank Research Centre for Infectious Diseases (KUISCID), Istanbul, Turkey.GarciaFedericoFEuropean Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Greece; Servicio de Microbiología Clínica, Hospital Universitario Clínico San Cecilio, Instituto de Investigación Biosanitaria, Ibs. Granada, Granada, Spain; Centro de Investigación Biomédicaen Red Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain.Morfin-SherpaFlorenceFEuropean Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Greece; Laboratory of Virology, Institut des Agents Infectieux, National Reference Centre for Respiratory Viruses, Hospices Civils de Lyon, Université Claude Bernard Lyon1, Lyon, France.DimopoulouDimitraDEuropean Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Greece; Second Department of Paediatrics, "P. and A. Kyriakou" Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.DimopoulouKonstantinaKDepartment of Gastroenterology, Hippokration General Hospital of Athens, Athens, Greece.ZelliSilviaSDipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy.de SalazarAdolfoAServicio de Microbiología Clínica, Hospital Universitario Clínico San Cecilio, Instituto de Investigación Biosanitaria, Ibs. Granada, Granada, Spain; Centro de Investigación Biomédicaen Red Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain.ReiterRiekeRInstitute of Laboratory Medicine, Universities of Giessen and Marburg Lung Centre (UGMLC), Philipps University Marburg, German Centre for Lung Research (DZL), Marburg, Germany.JanochaHannahHInstitute of Laboratory Medicine, Universities of Giessen and Marburg Lung Centre (UGMLC), Philipps University Marburg, German Centre for Lung Research (DZL), Marburg, Germany.GrossiAdrianoALocal Health Authority ASL Roma 1, Rome, Italy.OmonyJimmyJInstitute for Asthma and Allergy Prevention (IAP), Helmholtz Zentrum Munich, German Research Centre for Environmental Health (GmbH), Munich, Germany.SkevakiChrysanthiCEuropean Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Greece; Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Centre (UGMLC), Philipps University Marburg, German Centre for Lung Research (DZL), Marburg, Germany. Electronic address: chrysanthi.skevaki@uk-gm.de.engJournal Article20230422
EnglandClin Microbiol Infect95164201198-743XIMHumansCOVID-19diagnosisSARS-CoV-2Communicable DiseasesDiagnostic Techniques and ProceduresCOVID-19 TestingCOVID-19DiagnosisGuidelinesSARS-CoV-2Testing
2023212023413202341620236191392023424041202342319352023422ppublish37088423PMC1012255210.1016/j.cmi.2023.04.019S1198-743X(23)00192-1Fragkou P.C., De Angelis G., Menchinelli G., Can F., Garcia F., Morfin-Sherpa F., et al. ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2. Clin Microbiol Infect. 2022;28:812–822. doi: 10.1016/J.CMI.2022.02.011.10.1016/J.CMI.2022.02.011PMC886394935218978Brümmer L.E., Katzenschlager S., McGrath S., Schmitz S., Gaeddert M., Erdmann C., et al. Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: an updated systematic review and meta-analysis with meta-regression analyzing influencing factors. PLOS Med. 2022;19 doi: 10.1371/JOURNAL.PMED.1004011.10.1371/JOURNAL.PMED.1004011PMC918709235617375Goupil-Sormany I., Longtin J., Dumaresq J., Jacob-Wagner M., Bouchard F., Romero L., et al. The PRONTO study: clinical performance of ID NOW in individuals with compatible SARS-CoV-2 symptoms in walk-in centres-accelerated turnaround time for contact tracing. Can Commun Dis Rep. 2021;47:534–542. doi: 10.14745/CCDR.V47I12A04.10.14745/CCDR.V47I12A04PMC869939635018141Houston H., Gupta-Wright A., Toke-Bjolgerud E., Biggin-Lamming J., John L. Diagnostic accuracy and utility of SARS-CoV-2 antigen lateral flow assays in medical admissions with possible COVID-19. J Hosp Infect. 2021;110:203–205. doi: 10.1016/J.JHIN.2021.01.018.10.1016/J.JHIN.2021.01.018PMC784857633539935Jung C., Levy C., Varon E., Biscardi S., Batard C., Wollner A., et al. Diagnostic accuracy of SARS-CoV-2 antigen detection test in children: a real-life study. Front Pediatr. 2021;9 doi: 10.3389/FPED.2021.647274.10.3389/FPED.2021.647274PMC832123634336732Kritikos A., Caruana G., Brouillet R., Miroz J.P., Abed-Maillard S., Stieger G., et al. Sensitivity of rapid antigen testing and RT-PCR performed on nasopharyngeal swabs versus saliva samples in COVID-19 hospitalized patients: results of a Prospective Comparative Trial (RESTART) Microorganisms. 2021;9:1910. doi: 10.3390/MICROORGANISMS9091910.10.3390/MICROORGANISMS9091910PMC846472234576805Nagura-Ikeda M., Imai K., Tabata S., Miyoshi K., Murahara N., Mizuno T., et al. Clinical evaluation of self-collected saliva by quantitative reverse transcription-PCR (RT-qPCR), direct RT-qPCR, reverse transcription-loop-mediated isothermal amplification, and a rapid antigen test to diagnose COVID-19. J Clin Microbiol. 2020;58 doi: 10.1128/JCM.01438-20. e01438–20.10.1128/JCM.01438-20PMC744866332636214Nomoto H., Yamamoto K., Yamada G., Suzuki M., Kinoshita N., Takasaki J., et al. Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: the potential contribution to alleviating isolation of COVID-19 patients. J Infect Chemother. 2021;27:1669–1673. doi: 10.1016/J.JIAC.2021.08.015.10.1016/J.JIAC.2021.08.015PMC836343234454833Shaikh N., Friedlander E.J., Tate P.J., Liu H., Chang C.C.H., Wells A., et al. Performance of a rapid SARS-CoV-2 antigen detection assay in symptomatic children. Pediatrics. 2021;148 doi: 10.1542/PEDS.2021-050832.10.1542/PEDS.2021-05083234039718Shidlovskaya E.V., Kuznetsova N.A., Divisenko E.V., Nikiforova M.A., Siniavin A.E., Ogarkova D.A., et al. The value of rapid antigen tests for identifying carriers of viable SARS-CoV-2. Viruses. 2021;13:2012. doi: 10.3390/V13102012.10.3390/V13102012PMC853747634696442Abdul-Mumin A., Abubakari A., Agbozo F., Abdul-Karim A., Nuertey B.D., Mumuni K., et al. Field evaluation of specificity and sensitivity of a standard SARS-CoV-2 antigen rapid diagnostic test: a prospective study at a teaching hospital in Northern Ghana. MedRxiv. 2021:2021. doi: 10.1101/2021.06.03.21258300.10.1101/2021.06.03.21258300PMC1002117436962111Adnan N., Khandker S.S., Haq A., Chaity M.A., Khalek A., Nazim A.Q., et al. Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition. Expert Rev Anti Infect Ther. 2022;20:473–481. doi: 10.1080/14787210.2021.1976144.10.1080/14787210.2021.1976144PMC844276234477019Akingba O.L., Sprong K., Marais G., Hardie D.R. Field performance evaluation of the PanBio rapid SARS-CoV-2 antigen assay in an epidemic driven by the B.1.351 variant in the Eastern Cape, South Africa. J Clin Virol Plus. 2021;1 doi: 10.1016/J.JCVP.2021.100013.10.1016/J.JCVP.2021.100013PMC802560235262001Albert E., Torres I., Bueno F., Huntley D., Molla E., Fernández-Fuentes M.Á., et al. Field evaluation of a rapid antigen test (PanBioTM COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres. Clin Microbiol Infect. 2021;27:472.e7–472.e10. doi: 10.1016/J.CMI.2020.11.004.10.1016/J.CMI.2020.11.004PMC766207533189872Alemany A., Baró B., Ouchi D., Rodó P., Ubals M., Corbacho-Monné M., et al. Analytical and clinical performance of the PanBio COVID-19 antigen-detecting rapid diagnostic test. J Infect. 2021;82:186–230. doi: 10.1016/J.JINF.2020.12.033.10.1016/J.JINF.2020.12.033PMC778831733421447Aoki K., Nagasawa T., Ishii Y., Yagi S., Kashiwagi K., Miyazaki T., et al. Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2. J Infect Chemother. 2021;27:319–322. doi: 10.1016/J.JIAC.2020.11.015.10.1016/J.JIAC.2020.11.015PMC775734333388232Bachman C.M., Grant B.D., Anderson C.E., Alonzo L.F., Garing S., Byrnes S.A., et al. Clinical validation of an open-access SARS-COV-2 antigen detection lateral flow assay, compared to commercially available assays. PLOS ONE. 2021;16 doi: 10.1371/JOURNAL.PONE.0256352.10.1371/JOURNAL.PONE.0256352PMC837060334403456Bianco G., Boattini M., Barbui A.M., Scozzari G., Riccardini F., Coggiola M., et al. Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection. J Clin Virol. 2021;139 doi: 10.1016/J.JCV.2021.104838.10.1016/J.JCV.2021.104838PMC805804833946040Boum Y., Fai K.N., Nikolay B., Mboringong A.B., Bebell L.M., Ndifon M., et al. Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study. Lancet Infect Dis. 2021;21:1089–1096. doi: 10.1016/S1473-3099(21)00132-8.10.1016/S1473-3099(21)00132-8PMC799392933773618Bulilete O., Lorente P., Leiva A., Carandell E., Oliver A., Rojo E., et al. Evaluation of the PanBioTM rapid antigen test for SARS-CoV-2 in primary health care centers and test sites. MedRxiv. 2020:2020. doi: 10.1101/2020.11.13.20231316.10.1101/2020.11.13.20231316de O Cardoso J.M., Roatt B.M., de A Vieira P.M., de Paiva N.C.N., Bernardes-Souza B., Lisboa O.C., et al. Performance of the Wondfo 2019-nCoV antigen test using self-collected nasal versus professional-collected nasopharyngeal swabs in symptomatic SARS-CoV-2 infection. Diagnosis (Berl) 2022;9:398–402. doi: 10.1515/DX-2022-0003.10.1515/DX-2022-000335285222Caruana G., Croxatto A., Kampouri E., Kritikos A., Opota O., Foerster M., et al. Implementing SARS-CoV-2 rapid antigen testing in the emergency ward of a Swiss University Hospital: the INCREASE Study. Microorganisms. 2021;9:798. doi: 10.3390/MICROORGANISMS9040798.10.3390/MICROORGANISMS9040798PMC806974933920307Cerutti F., Burdino E., Milia M.G., Allice T., Gregori G., Bruzzone B., et al. Urgent need of rapid tests for SARS CoV-2 antigen detection: evaluation of the SD-Biosensor antigen test for SARS-CoV-2. J Clin Virol. 2020;132 doi: 10.1016/J.JCV.2020.104654.10.1016/J.JCV.2020.104654PMC752264933053494Courtellemont L., Guinard J., Guillaume C., Giaché S., Rzepecki V., Seve A., et al. High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infection. J Med Virol. 2021;93:3152–3157. doi: 10.1002/JMV.26896.10.1002/JMV.26896PMC801458033615487Deslandes V., Clark E., Thiruganasambandamoorthy V., Desjardins M. Implementation of the Abbott ID Now COVID-19 assay at a tertiary care center: a prospective pragmatic implementation study during the third wave of SARS-CoV-2 in Ontario. Diagn Microbiol Infect Dis. 2022;102 doi: 10.1016/J.DIAGMICROBIO.2021.115609.10.1016/J.DIAGMICROBIO.2021.115609PMC862634834933188Drain P.K., Ampajwala M., Chappel C., Gvozden A.B., Hoppers M., Wang M., et al. A rapid, high-sensitivity SARS-CoV-2 nucleocapsid immunoassay to aid diagnosis of acute COVID-19 at the point of care: a clinical performance study. Infect Dis Ther. 2021;10:753–761. doi: 10.1007/S40121-021-00413-X.10.1007/S40121-021-00413-XPMC790403833629225Drevinek P., Hurych J., Kepka Z., Briksi A., Kulich M., Zajac M., et al. The sensitivity of SARS-CoV-2 antigen tests in the view of large-scale testing. MedRxiv. 2020:2020. doi: 10.1101/2020.11.23.20237198.10.1101/2020.11.23.2023719834641689Eleftheriou I., Dasoula F., Dimopoulou D., Lebessi E., Serafi E., Spyridis N., et al. Real-life evaluation of a COVID-19 rapid antigen detection test in hospitalized children. J Med Virol. 2021;93:6040–6044. doi: 10.1002/JMV.27149.10.1002/JMV.27149PMC842701434156112Elli S., Blasi F., Brignolo B., Ceriotti F., Gori A., Piatti A., et al. Diagnostic accuracy of rapid antigen test for COVID-19 in an emergency department. Diagn Microbiol Infect Dis. 2022;102 doi: 10.1016/J.DIAGMICROBIO.2022.115635.10.1016/J.DIAGMICROBIO.2022.115635PMC876111535216863Farhana A., Zahoor D., Wani S., Khan R.A., Nasir R., Kanth F. Diagnostic utility and performance of rapid antigen test in SARS CoV-2 in symptomatic and asymptomatic patients during the second pandemic wave in Kashmir, North India. Indian J Med Microbiol. 2022;40:572–576. doi: 10.1016/J.IJMMB.2022.06.007.10.1016/J.IJMMB.2022.06.007PMC924941135787334Fenollar F., Bouam A., Ballouche M., Fuster L., Prudent E., Colson P., et al. Evaluation of the PanBio COVID-19 rapid antigen detection test device for the screening of patients with COVID-19. J Clin Microbiol. 2021;59 doi: 10.1128/JCM.02589-20. e02589–20.10.1128/JCM.02589-20PMC811114533139420Filgueiras P.S., Corsini C.A., Almeida N.B., Assis J.V., Luysa M., Pedrosa C., et al. COVID-19 rapid antigen test at hospital admission associated to the knowledge of individual risk factors allow overcoming the difficulty of managing suspected patients in hospitals COVID-19 rapid antigen test facilitates the management of suspected patients on hospital admission. MedRxiv. 2021:2021. doi: 10.1101/2021.01.06.21249282.10.1101/2021.01.06.21249282Foundation for Innovative New Diagnostics (FIND) COVID-19 test directory – FIND. https://www.finddx.org/tools-and-resources/dxconnect/test-directories/covid-19-test-directory/ n.d.Fitoussi F., Tonen-Wolyec S., Awaida N., Dupont R., Bélec L. Analytical performance of the point-of-care BIOSYNEX COVID-19 Ag BSS for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: a prospective field evaluation during the COVID-19 third wave in France. Infection. 2022;50:625–633. doi: 10.1007/S15010-021-01723-5.10.1007/S15010-021-01723-5PMC854235934689310Fourati S, Audureau É, Chevaliez S, Pawlotsky J-M. Évaluation de la performance diagnostique des tests rapides d’orientation diagnostique antigéniques COVID-19. n.d. https://www.calameo.com/read/004021827da342e75785b?utm_source=platform&utm_medium=email&utm_campaign=book_created&utm_content=html&utm_term=4021827 [Accessed 15 August 2022].Frediani J.K., Levy J.M., Rao A., Bassit L., Figueroa J., Vos M.B., et al. Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration. Sci Rep. 2021;11 doi: 10.1038/S41598-021-94055-1.10.1038/S41598-021-94055-1PMC828547434272449Freire M.L., Alves L.L., de Souza C.S., Saliba J.W., Faria V., Pedras M.J., et al. Performance differences among commercially available antigen rapid tests for COVID-19 in Brazil. PLOS ONE. 2022;17 doi: 10.1371/JOURNAL.PONE.0269997.10.1371/JOURNAL.PONE.0269997PMC920287735709075Garcia-Cardenas F., Peñaloza F., Bertin-Montoya J., Valdéz-Vázquez R., Franco A., Cortés R., et al. Analytical performances of the COVISTIXTM antigen rapid test for SARS-CoV-2 detection in an unselected population (all-comers) Pathogens. 2022;11:628. doi: 10.3390/PATHOGENS11060628.10.3390/PATHOGENS11060628PMC922999935745482González-Donapetry P., García-Clemente P., Bloise I., García-Sánchez C., Sánchez Castellano M.Á., Romero M.P., et al. Think of the children: evaluation of SARS-CoV-2 rapid antigen test in pediatric population. Pediatr Infect Dis J. 2021;40:385–388. doi: 10.1097/INF.0000000000003101.10.1097/INF.000000000000310133605674Gupta A., Khurana S., Das R., Srigyan D., Singh A., Mittal A., et al. Rapid chromatographic immunoassay-based evaluation of COVID-19: a cross-sectional, diagnostic test accuracy study & its implications for COVID-19 management in India. Indian J Med Res. 2021;153:126–131. doi: 10.4103/IJMR.IJMR_3305_20.10.4103/IJMR.IJMR_3305_20PMC818407833818469Halfon P., Penaranda G., Khiri H., Garcia V., Drouet H., Philibert P., et al. An optimized stepwise algorithm combining rapid antigen and RT-qPCR for screening of COVID-19 patients. PLOS ONE. 2021;16 doi: 10.1371/JOURNAL.PONE.0257817.10.1371/JOURNAL.PONE.0257817PMC846000234555117Harris D.T., Badowski M., Jernigan B., Sprissler R., Edwards T., Cohen R., et al. SARS-CoV-2 rapid antigen testing of symptomatic and asymptomatic individuals on the University of Arizona Campus. Biomedicines. 2021;9:539. doi: 10.3390/BIOMEDICINES9050539.10.3390/BIOMEDICINES9050539PMC815089834066047Ifko M., Skvarc M. Use of immunochromatographic SARS-CoV-2 antigen testing in eight long-term care facilities for the elderly. Healthcare (Basel) 2021;9:868. doi: 10.3390/HEALTHCARE9070868.10.3390/HEALTHCARE9070868PMC830749934356246Jegerlehner S., Suter-Riniker F., Jent P., Bittel P., Nagler M. Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings. Int J Infect Dis. 2021;109:118–122. doi: 10.1016/J.IJID.2021.07.010.10.1016/J.IJID.2021.07.010PMC826049634242764Johnson C., Ferguson K., Smith T., Wallace D., McConnell K., Conserve D., et al. Evaluation of the PanBio SARS-CoV-2 rapid antigen detection test in the Bahamas. MedRxiv. 2021:2021. doi: 10.1101/2021.07.13.21260402.10.1101/2021.07.13.21260402Karuga I., Munyua P., Ochieng C., Juma B., Amoth P., Kuria F., et al. Diagnostic accuracy of the PanBioTM COVID-19 antigen rapid test device for SARS-CoV-2 detection in Kenya, 2021: a field evaluation. MedRxiv. 2022:2022. doi: 10.1101/2022.05.23.22275439.10.1101/2022.05.23.22275439PMC987666136696882Kernéis S., Elie C., Fourgeaud J., Choupeaux L., Delarue S.M., Alby M.L., et al. Accuracy of saliva and nasopharyngeal sampling for detection of SARS-CoV-2 in community screening: a multicentric cohort study. Eur J Clin Microbiol Infect Dis. 2021;40:2379–2388. doi: 10.1007/S10096-021-04327-X.10.1007/S10096-021-04327-XPMC832940934342768Kim H.W., Park M., Lee J.H. Clinical evaluation of the rapid STANDARD Q COVID-19 Ag test for the screening of severe acute respiratory syndrome coronavirus 2. Ann Lab Med. 2022;42:100–104. doi: 10.3343/ALM.2022.42.1.100.10.3343/ALM.2022.42.1.100PMC836822434374355King C., Weever E.L., Henry M., Steingrover R., Fleming C., Panneflek R., et al. Validation of the PanBioTM COVID-19 antigen rapid test (Abbott) to screen for SARS-CoV-2 infection in Sint Maarten: a diagnostic accuracy study. MedRxiv. 2021:2021. doi: 10.1101/2021.09.23.21260526.10.1101/2021.09.23.21260526Kiyasu Y., Takeuchi Y., Akashi Y., Kato D., Kuwahara M., Muramatsu S., et al. Prospective analytical performance evaluation of the QuickNaviTM-COVID19 Ag for asymptomatic individuals. J Infect Chemother. 2021;27:1489–1492. doi: 10.1016/J.JIAC.2021.07.005.10.1016/J.JIAC.2021.07.005PMC826654534301485Klajmon A., Olechowska-Jarząb A., Salamon D., Sroka-Oleksiak A., Brzychczy-Włoch M., Gosiewski T. Comparison of antigen tests and qPCR in rapid diagnostics of infections caused by SARS-CoV-2 virus. Viruses. 2021;14:17. doi: 10.3390/V14010017.10.3390/V14010017PMC877900735062221Koeleman J.G.M., Brand H., de Man S.J., Ong D.S.Y. Clinical evaluation of rapid point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021;40:1975–1981. doi: 10.1007/S10096-021-04274-7.10.1007/S10096-021-04274-7PMC814030934021840Kolwijck E., Brouwers-Boers M., Broertjes J., van Heeswijk K., Runderkamp N., Meijer A., et al. Validation and implementation of the PanBio COVID-19 Ag rapid test for the diagnosis of SARS-CoV-2 infection in symptomatic hospital healthcare workers. Infect Prev Pract. 2021;3 doi: 10.1016/J.INFPIP.2021.100142.10.1016/J.INFPIP.2021.100142PMC805039734316580Korenkov M., Poopalasingam N., Madler M., Vanshylla K., Eggeling R., Wirtz M., et al. Assessment of SARS-CoV-2 infectivity by a rapid antigen detection test. MedRxiv. 2021:2021. doi: 10.1101/2021.03.30.21254624.10.1101/2021.03.30.21254624Krüger L.J., Gaeddert M., Tobian F., Lainati F., Gottschalk C., Klein J.A.F., et al. The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2-evaluation of the accuracy and ease-of-use. PLOS ONE. 2021;16 doi: 10.1371/JOURNAL.PONE.0247918.10.1371/JOURNAL.PONE.0247918PMC815899634043631Kurihara Y., Kiyasu Y., Akashi Y., Takeuchi Y., Narahara K., Mori S., et al. The evaluation of a novel digital immunochromatographic assay with silver amplification to detect SARS-CoV-2. J Infect Chemother. 2021;27:1493–1497. doi: 10.1016/J.JIAC.2021.07.006.10.1016/J.JIAC.2021.07.006PMC827547534294528L’Huillier A.G., Lacour M., Sadiku D., Gadiri M.A., De Siebenthal L., Schibler M., et al. Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting. J Clin Microbiol. 2021;59 doi: 10.1128/JCM.00991-21.10.1128/JCM.00991-21PMC837303034190574Landaas E.T., Storm M.L., Tollånes M.C., Barlinn R., Kran A.M.B., Bragstad K., et al. Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort. J Clin Virol. 2021;137 doi: 10.1016/J.JCV.2021.104789.10.1016/J.JCV.2021.104789PMC794480333736946Leber W., Lammel O., Siebenhofer A., Redlberger-Fritz M., Panovska-Griffiths J., Czypionka T. Comparing the diagnostic accuracy of point-of-care lateral flow antigen testing for SARS-CoV-2 with RT-PCR in primary care (REAP-2) EClinicalMedicine. 2021;38 doi: 10.1016/J.ECLINM.2021.101011.10.1016/J.ECLINM.2021.101011PMC827722434278276Linares M., Pérez-Tanoira R., Carrero A., Romanyk J., Pérez-García F., Gómez-Herruz P., et al. PanBio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms. J Clin Virol. 2020;133 doi: 10.1016/J.JCV.2020.104659.10.1016/J.JCV.2020.104659PMC756160333160179Lindner A.K., Nikolai O., Kausch F., Wintel M., Hommes F., Gertler M., et al. Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with self-collected nasal swab versus professional-collected nasopharyngeal swab. Eur Respir J. 2021;57 doi: 10.1183/13993003.03961-2020.10.1183/13993003.03961-2020PMC773675233303544Lindner A.K., Nikolai O., Rohardt C., Kausch F., Wintel M., Gertler M., et al. Diagnostic accuracy and feasibility of patient self-testing with a SARS-CoV-2 antigen-detecting rapid test. J Clin Virol. 2021;141 doi: 10.1016/J.JCV.2021.104874.10.1016/J.JCV.2021.104874PMC816372634144452Lunca C., Cojocaru C., Gurzu I.L., Petrariu F.D., Cojocaru E. Performance of antigenic detection of SARS-CoV-2 in nasopharyngeal samples. MedRxiv. 2021:2021. doi: 10.1101/2021.07.12.21260263.10.1101/2021.07.12.21260263Lv Y., Ma Y., Si Y., Zhu X., Zhang L., Feng H., et al. Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease. Biosci Trends. 2021;15:93–99. doi: 10.5582/BST.2021.01090.10.5582/BST.2021.0109033776018Masiá M., Fernández-González M., Sánchez M., Carvajal M., García J.A., Gonzalo-Jiménez N., et al. Nasopharyngeal PanBio COVID-19 antigen performed at point-of-care has a high sensitivity in symptomatic and asymptomatic patients with higher risk for transmission and older age. Open Forum Infect Dis. 2021;8:ofab059. doi: 10.1093/OFID/OFAB059.10.1093/OFID/OFAB059PMC792861533723512Mboumba Bouassa R.S., Veyer D., Péré H., Bélec L. Analytical performances of the point-of-care SIENNATM COVID-19 antigen rapid test for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: a prospective evaluation during the COVID-19 second wave in France. Int J Infect Dis. 2021;106:8–12. doi: 10.1016/J.IJID.2021.03.051.10.1016/J.IJID.2021.03.051PMC797075333746093Menchinelli G., De Angelis G., Cacaci M., Liotti F.M., Candelli M., Palucci I., et al. SARS-CoV-2 antigen detection to expand testing capacity for COVID-19: results from a hospital emergency department testing site. Diagnostics (Basel) 2021;11:1211. doi: 10.3390/DIAGNOSTICS11071211.10.3390/DIAGNOSTICS11071211PMC830466534359294Merino P., Guinea J., Muñoz-Gallego I., González-Donapetry P., Galán J.C., Antona N., et al. Multicenter evaluation of the PanBioTM COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection. Clin Microbiol Infect. 2021;27:758–761. doi: 10.1016/J.CMI.2021.02.001.10.1016/J.CMI.2021.02.001PMC788423433601009Mertens P., De Vos N., Martiny D., Jassoy C., Mirazimi A., Cuypers L., et al. Development and potential usefulness of the COVID-19 Ag Respi-Strip diagnostic assay in a pandemic context. Front Med (Lausanne) 2020;7:225. doi: 10.3389/FMED.2020.00225.10.3389/FMED.2020.00225PMC722779032574326Micocci M., Buckle P., Hayward G., Allen A.J., Davies K., Kierkegaard P., et al. Point of care testing using rapid automated antigen testing for SARS-COV-2 in care homes – an exploratory safety, usability and diagnostic agreement evaluation. MedRxiv. 2021:2021. doi: 10.1101/2021.04.22.21255948.10.1101/2021.04.22.21255948Mirahmadizadeh A., Yeganeh B.S., Hassanzadeh J., Badiee L., Vali M., Maleki Z., et al. Value of rapid antigen test in comparison with reverse transcriptase-polymerase chain reaction method in the diagnosis of COVID-19. Mediterr J Infect Microbe Antimicrob. 2022;11 doi: 10.4274/MJIMA.GALENOS.2021.2021.2.10.4274/MJIMA.GALENOS.2021.2021.2Möckel M., Corman V.M., Stegemann M.S., Hofmann J., Stein A., Jones T.C., et al. SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department. Biomarkers. 2021;26:213–220. doi: 10.1080/1354750X.2021.1876769.10.1080/1354750X.2021.1876769PMC789829633455451Moraleda C., Domínguez-Rodríguez S., Mesa J.M., García-Sánchez P., De La Serna M., Alonso-Cadenas J.A., et al. Oral saliva swab reverse transcription PCR for Covid-19 in the paediatric population. Arch Dis Child. 2022;107:1051–1058. doi: 10.1136/ARCHDISCHILD-2021-323712.10.1136/ARCHDISCHILD-2021-32371235688603Nordgren J., Sharma S., Olsson H., Jämtberg M., Falkeborn T., Svensson L., et al. SARS-CoV-2 rapid antigen test: high sensitivity to detect infectious virus. J Clin Virol. 2021;140 doi: 10.1016/J.JCV.2021.104846.10.1016/J.JCV.2021.104846PMC810508133971580Orsi A., Pennati B.M., Bruzzone B., Ricucci V., Ferone D., Barbera P., et al. On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic. J Virol Methods. 2021;295 doi: 10.1016/J.JVIROMET.2021.114201.10.1016/J.JVIROMET.2021.114201PMC816177634058287Pérez-García F., Romanyk J., Gómez-Herruz P., Arroyo T., Pérez-Tanoira R., Linares M., et al. Diagnostic performance of CerTest and PanBio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection. J Clin Virol. 2021;137 doi: 10.1016/J.JCV.2021.104781.10.1016/J.JCV.2021.104781PMC789740733639492Pandey A.K., Mohanty A., Hada V., Rath R.S., Kumar S., Kishore S., et al. Comparison of the rapid antigen testing method with RT-qPCR for the diagnosis of COVID-19. Cureus. 2021;13 doi: 10.7759/CUREUS.17405.10.7759/CUREUS.17405PMC845939034589316Porte L., Legarraga P., Iruretagoyena M., Vollrath V., Munita J.M., Araos R., et al. Rapid SARS-CoV-2 antigen detection by immunofluorescence-a new tool to detect 1 infectivity 2 3. Medrvix. 2020 doi: 10.1101/2020.10.04.20206466.10.1101/2020.10.04.20206466Porte L., Legarraga P., Vollrath V., Aguilera X., Munita J.M., Araos R., et al. Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples. Int J Infect Dis. 2020;99:328–333. doi: 10.1016/J.IJID.2020.05.098.10.1016/J.IJID.2020.05.098PMC726323632497809Ptasinska A., Whalley C., Bosworth A., Poxon C., Bryer C., Machin N., et al. Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations. Clin Microbiol Infect. 2021;27:1348.e1–1348.e7. doi: 10.1016/J.CMI.2021.04.008.10.1016/J.CMI.2021.04.008PMC806489733901668Regev-Yochay G., Kriger O., Mina M.J., Beni S., Rubin C., Mechnik B., et al. Real world performance of SARS-CoV-2 antigen rapid diagnostic tests in various clinical settings. Infect Control Hosp Epidemiol. 2022:1–20. doi: 10.1017/ICE.2022.3.10.1017/ICE.2022.335232504Ristić M., Nikolić N., Čabarkapa V., Turkulov V., Petrović V. Validation of the STANDARD Q COVID-19 antigen test in Vojvodina, Serbia. PLOS ONE. 2021;16 doi: 10.1371/JOURNAL.PONE.0247606.10.1371/JOURNAL.PONE.0247606PMC789936833617597Robinson M.L., Mirza A., Gallagher N., Boudreau A., Jacinto L.G., Yu T., et al. Limitations of molecular and antigen test performance for SARS-CoV-2 in symptomatic and asymptomatic COVID-19 contacts. J Clin Microbiol. 2022;60 doi: 10.1128/jcm.00187-22.10.1128/jcm.00187-22PMC929783935730949Rohde J., Himmel W., Hofinger C., Lâm T.-T., Schrader H., Wallstabe J., et al. Diagnostic accuracy and feasibility of a rapid SARS-CoV-2 antigen test in general practice-a prospective multicenter validation and implementation study. BMC Prim Care. 2022;23:149. doi: 10.1186/s12875-022-01756-1.10.1186/s12875-022-01756-1PMC918788435690722Schwob J.M., Miauton A., Petrovic D., Perdrix J., Senn N., Jaton K., et al. Antigen rapid tests, nasopharyngeal PCR and saliva PCR to detect SARS-CoV-2: a prospective comparative clinical trial. MedRxiv. 2020:2020. doi: 10.1101/2020.11.23.20237057.10.1101/2020.11.23.20237057PMC995596336827328Scohy A., Anantharajah A., Bodéus M., Kabamba-Mukadi B., Verroken A., Rodriguez-Villalobos H. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J Clin Virol. 2020;129 doi: 10.1016/J.JCV.2020.104455.10.1016/J.JCV.2020.104455PMC724027232485618Smith R.D., Johnson J.K., Clay C., Girio-Herrera L., Stevens D., Abraham M., et al. Clinical evaluation of Sofia Rapid Antigen Assay for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among emergency department to hospital admissions. Infect Control Hosp Epidemiol. 2022;43:968–973. doi: 10.1017/ICE.2021.281.10.1017/ICE.2021.281PMC837685034162449Stokes W., Berenger B.M., Portnoy D., Scott B., Szelewicki J., Singh T., et al. Clinical performance of the Abbott PanBio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19. Eur J Clin Microbiol Infect Dis. 2021;40:1721–1726. doi: 10.1007/S10096-021-04202-9.10.1007/S10096-021-04202-9PMC797946733742322Suzuki H., Akashi Y., Kato D., Takeuchi Y., Kiyasu Y., Terada N., et al. Analytical performance of the rapid qualitative antigen kit for the detection of SARS-CoV-2 during widespread circulation of the Omicron variant. J Infect Chemother. 2023;29:257–262. doi: 10.1016/J.JIAC.2022.11.006.10.1016/J.JIAC.2022.11.006PMC967593536417995Suzuki H., Akashi Y., Ueda A., Kiyasu Y., Takeuchi Y., Maehara Y., et al. Diagnostic performance of a novel digital immunoassay (RapidTesta SARS-CoV-2): a prospective observational study with nasopharyngeal samples. J Infect Chemother. 2022;28:78–81. doi: 10.1016/J.JIAC.2021.10.024.10.1016/J.JIAC.2021.10.024PMC854919034736814Takeuchi Y., Akashi Y., Kato D., Kuwahara M., Muramatsu S., Ueda A., et al. Diagnostic performance and characteristics of anterior nasal collection for the SARS-CoV-2 antigen test: a prospective study. Sci Rep. 2021;11 doi: 10.1038/S41598-021-90026-8.10.1038/S41598-021-90026-8PMC813168634006975Takeuchi Y., Akashi Y., Kato D., Kuwahara M., Muramatsu S., Ueda A., et al. The evaluation of a newly developed antigen test (QuickNaviTM-COVID19 Ag) for SARS-CoV-2: a prospective observational study in Japan. J Infect Chemother. 2021;27:890–894. doi: 10.1016/J.JIAC.2021.02.029.10.1016/J.JIAC.2021.02.029PMC793172433727026Terpos E., Ntanasis-Stathopoulos I., Skvarč M. Clinical application of a new SARS-CoV-2 antigen detection kit (colloidal gold) in the detection of COVID-19. Diagnostics (Basel) 2021;11:995. doi: 10.3390/DIAGNOSTICS11060995.10.3390/DIAGNOSTICS11060995PMC822920834070844Thirion-Romero I., Guerrero-Zúñiga D.S., Arias-Mendoza D.A., Cornejo-Juárez D.D.P., Meza-Meneses D.P., Torres-Erazo D.D.S., et al. Evaluation of PanBio rapid antigen test for SARS-CoV-2 in symptomatic patients and their contacts: a multicenter study. Int J Infect Dis. 2021;113:218–224. doi: 10.1016/J.IJID.2021.10.027.10.1016/J.IJID.2021.10.027PMC852611534678504Thommes L., Burkert F.R., Öttl K.W., Goldin D., Loacker L., Lanser L., et al. Comparative evaluation of four SARS-CoV-2 antigen tests in hospitalized patients. Int J Infect Dis. 2021;105:144–146. doi: 10.1016/J.IJID.2021.02.052.10.1016/J.IJID.2021.02.052PMC788899433609774Torres I., Poujois S., Albert E., Álvarez G., Colomina J., Navarro D. Point-of-care evaluation of a rapid antigen test (CLINITEST® Rapid COVID-19 Antigen Test) for diagnosis of SARS-CoV-2 infection in symptomatic and asymptomatic individuals. J Infect. 2021;82:e11–e12. doi: 10.1016/J.JINF.2021.02.010.10.1016/J.JINF.2021.02.010PMC787905633587922de Michelena P., Torres I., Ramos-García Á, Gosalbes V., Ruiz N., Sanmartín A., et al. Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant. MedRxiv. 2022:2022. doi: 10.1101/2022.02.02.22270295.10.1101/2022.02.02.22270295PMC886332835217106Tsai S.C., Lee W.S., Chen P.Y., Hung S.H. Real world clinical performance of SARS-CoV-2 rapid antigen tests in suspected COVID-19 cases in Taiwan. J Formos Med Assoc. 2021;120:2042–2043. doi: 10.1016/J.JFMA.2021.07.011.10.1016/J.JFMA.2021.07.011PMC827548734301424Venekamp R.P., Veldhuijzen I.K., Moons K.G.M., van den Bijllaardt W., Pas S.D., Lodder E.B., et al. Detection of SARS-CoV-2 infection in the general population by three prevailing rapid antigen tests: cross-sectional diagnostic accuracy study. BMC Med. 2022;20:1–13. doi: 10.1186/S12916-022-02300-9/TABLES/3.10.1186/S12916-022-02300-9/TABLES/3PMC886604035197052Veyrenche N., Bolloré K., Pisoni A., Bedin A.S., Mondain A.M., Ducos J., et al. Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission. J Med Virol. 2021;93:3069–3076. doi: 10.1002/JMV.26855.10.1002/JMV.26855PMC801359933554363Villaverde S., Domínguez-Rodríguez S., Sabrido G., Pérez-Jorge C., Plata M., Romero M.P., et al. Diagnostic accuracy of the PanBio SARS-CoV-2 antigen rapid test compared with Rt-Pcr testing of nasopharyngeal samples in the pediatric population. J Pediatr. 2021;232:287–289. doi: 10.1016/J.JPEDS.2021.01.027. e4.10.1016/J.JPEDS.2021.01.027PMC782613733484697Weitzel T., Legarraga P., Iruretagoyena M., Pizarro G., Vollrath V., Araos R., et al. Comparative evaluation of four rapid SARS-CoV-2 antigen detection tests using universal transport medium. Travel Med Infect Dis. 2020;39 doi: 10.1016/J.TMAID.2020.101942.10.1016/J.TMAID.2020.101942PMC770882633278609Yamamoto K., Suzuki M., Yamada G., Sudo T., Nomoto H., Kinoshita N., et al. Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission. Int J Infect Dis. 2021;104:65–72. doi: 10.1016/J.IJID.2020.12.079.10.1016/J.IJID.2020.12.079PMC777836633401037Yin N., Debuysschere C., Decroly M., Bouazza F.Z., Collot V., Martin C., et al. SARS-CoV-2 diagnostic tests: algorithm and field evaluation from the near patient testing to the automated diagnostic platform. Front Med (Lausanne) 2021;8 doi: 10.3389/FMED.2021.650581.10.3389/FMED.2021.650581PMC805584333889587Yokota I., Sakurazawa T., Sugita J., Iwasaki S., Yasuda K., Yamashita N., et al. Performance of qualitative and quantitative antigen tests for SARS-CoV-2 using saliva. Infect Dis Rep. 2021;13:742–747. doi: 10.3390/IDR13030069.10.3390/IDR13030069PMC839584934449650Yokota I., Sakurazawa T., Sugita J., Iwasaki S., Yasuda K., Yamashita N., et al. Performance of qualitative and quantitative antigen tests for SARS-CoV-2 in early symptomatic patients using saliva. MedRxiv. 2020:2020. doi: 10.1101/2020.11.06.20227363.10.1101/2020.11.06.20227363PMC839584934449650Bond K.A., Smith B., Gardiner E., Liew K.C., Williams E., Walsham N., et al. Utility of SARS-CoV-2 rapid antigen testing for patient triage in the emergency department: a clinical implementation study in Melbourne, Australia. Lancet Reg Health West Pac. 2022;25 doi: 10.1016/J.LANWPC.2022.100486.10.1016/J.LANWPC.2022.100486PMC915086335655473Christensen K., Ren H., Chen S., Cooper C.K., Young S. Clinical evaluation of BD VeritorTM SARS-CoV-2 and Flu A+B assay for point-of-care (POC) system. MedRxiv. 2021:2021. doi: 10.1101/2021.05.04.21256323.10.1101/2021.05.04.21256323PMC904508535412847Drain P.K., Bemer M., Morton J.F., Dalmat R., Abdille H., Thomas K.K., et al. Accuracy of 2 rapid antigen tests during 3 phases of SARS-CoV-2 variants. JAMA Netw Open. 2022;5:E2228143. doi: 10.1001/JAMANETWORKOPEN.2022.28143.10.1001/JAMANETWORKOPEN.2022.28143PMC940377836001317Ford L., Whaley M.J., Shah M.M., Salvatore P.P., Segaloff H.E., Delaney A., et al. Antigen test performance among children and adults at a SARS-CoV-2 community testing site. Pediatr Infect Dis J. 2021;10:1052–1061. doi: 10.1093/JPIDS/PIAB081.10.1093/JPIDS/PIAB081PMC893244134468732James A.E., Gulley T., Kothari A., Holder K., Garner K., Patil N. Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees. Infect Control Hosp Epidemiol. 2022;43:99–101. doi: 10.1017/ICE.2021.20.10.1017/ICE.2021.20PMC787090833487197Kahn M., Schuierer L., Bartenschlager C., Zellmer S., Frey R., Freitag M., et al. Performance of antigen testing for diagnosis of COVID-19: a direct comparison of a lateral flow device to nucleic acid amplification based tests. BMC Infect Dis. 2021;21:798. doi: 10.1186/S12879-021-06524-7.10.1186/S12879-021-06524-7PMC835430134376187Jakobsen K.K., Schmidt Jensen J., Todsen T., Lippert F., Martel C.J.-M., Klokker M., et al. Detection of SARS-CoV-2 infection by rapid antigen test in comparison with RT-PCR in a public setting. MedRxiv. 2021:2021. doi: 10.1101/2021.01.22.21250042.10.1101/2021.01.22.21250042Mehta A., Spencer B., Garg A., Kalmorge P., Gonzalez R.A.O., Taussig K., et al. Performance of Gazelle COVID-19 point-of-care test for detection of nucleocapsid antigen from SARS-CoV-2. MedRxiv. 2022:2022. doi: 10.1101/2022.03.23.22272094.10.1101/2022.03.23.22272094Moritz E.D., McKay S.L., Tobolowsky F.A., Lavoie S.P., Waltenburg M.A., Lecy K.D., et al. Repeated antigen testing among severe acute respiratory coronavirus virus 2 (SARS-CoV-2)-positive nursing home residents. Infect Control Hosp Epidemiol. 2022;43:1918–1921. doi: 10.1017/ICE.2021.370.10.1017/ICE.2021.370PMC871295934412728Nikolai O., Rohardt C., Tobian F., Junge A., Corman V.M., Jones T.C., et al. Anterior nasal versus nasal mid-turbinate sampling for a SARS-CoV-2 antigen-detecting rapid test: does localisation or professional collection matter? MedRxiv. 2021:2021. doi: 10.1101/2021.02.09.21251274.10.1101/2021.02.09.21251274PMC842545934445926Olearo F., Nörz D., Heinrich F., Sutter J.P., Roedel K., Schultze A., et al. Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR. J Clin Virol. 2021;137 doi: 10.1016/J.JCV.2021.104782.10.1016/J.JCV.2021.104782PMC792759133711691Parada-Ricart E., Gomez-Bertomeu F., Picó-Plana E., Olona-Cabases M. [Usefulness of the antigen for diagnosing SARS-CoV-2 infection in patients with and without symptoms] Enferm Infecc Microbiol Clin. 2021;39:357–358. doi: 10.1016/J.EIMC.2020.09.009.10.1016/J.EIMC.2020.09.009PMC811612934353515Pollock N.R., Jacobs J.R., Tran K., Cranston A.E., Smith S., O’Kane C.Y., et al. Performance and implementation evaluation of the Abbott BinaxNOW rapid antigen test in a high-throughput drive-through community testing site in Massachusetts. J Clin Microbiol. 2021;59 doi: 10.1128/JCM.00083-21. e00083–21.10.1128/JCM.00083-21PMC809185133622768Pollock N.R., Tran K., Jacobs J.R., Cranston A.E., Smith S., O’Kane C.Y., et al. Performance and operational evaluation of the access Bio CareStart rapid antigen test in a high-throughput drive-through community testing site in Massachusetts. Open Forum Infect Dis. 2021;8:ofab243. doi: 10.1093/OFID/OFAB243.10.1093/OFID/OFAB243PMC824462634250188Pray I.W., Ford L., Cole D., Lee C., Bigouette J.P., Abedi G.R., et al. Performance of an antigen-based test for asymptomatic and symptomatic SARS-CoV-2 testing at two university campuses – Wisconsin, September-October 2020. MMWR Morb Mortal Wkly Rep. 2021;69:1642–1647. doi: 10.15585/MMWR.MM695152A3.10.15585/MMWR.MM695152A3PMC919190533382679Salcedo N., Sena B.F., Qu X., Herrera B.B. Comparative evaluation of rapid isothermal amplification and antigen assays for screening testing of SARS-CoV-2. Viruses. 2022;14:468. doi: 10.3390/V14030468.10.3390/V14030468PMC895146635336875Savage H.R., Finch L., Body R., Watkins R.L., Hayward G., Cook E., et al. A prospective diagnostic evaluation of accuracy of self-taken and healthcare worker-taken swabs for rapid COVID-19 testing. PLOS ONE. 2022;17 doi: 10.1371/journal.pone.0270715.10.1371/journal.pone.0270715PMC924621835771760Schildgen V., Demuth S., Lüsebrink J., Schildgen O. Limits and opportunities of SARS-CoV-2 antigen rapid tests: an experienced-based perspective. Pathogens. 2021;10:1–7. doi: 10.3390/PATHOGENS10010038.10.3390/PATHOGENS10010038PMC782481833466537Schrom J., Marquez C., Pilarowski G., Wang C.Y., Mitchell A., Puccinelli R., et al. Comparison of SARS-CoV-2 reverse transcriptase polymerase chain reaction and BinaxNOW rapid antigen tests at a community site during an Omicron surge : a cross-sectional study. Ann Intern Med. 2022;175:682–690. doi: 10.7326/M22-0202.10.7326/M22-0202PMC894384435286144Shah M.M., Salvatore P.P., Ford L., Kamitani E., Whaley M.J., Mitchell K., et al. Performance of repeat BinaxNOW severe acute respiratory syndrome coronavirus 2 antigen testing in a community setting, Wisconsin, November 2020-December 2020. Clin Infect Dis. 2021;73:S54–S57. doi: 10.1093/CID/CIAB309.10.1093/CID/CIAB309PMC813546533909068Sood N., Shetgiri R., Rodriguez A., Jimenez D., Treminino S., Daflos A., et al. Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: implications for screening in a school setting. PLOS ONE. 2021;16 doi: 10.1371/JOURNAL.PONE.0249710.10.1371/JOURNAL.PONE.0249710PMC802117833819311Sun K.J., Vaeth M.J.E., Robinson M., Elhabashy M., Gupta I., Purekal S., et al. High sensitivity and NPV for BinaxNOW rapid antigen test in children at a mass testing site during prevalent Delta variant period. Microbiol Spectr. 2022;10 doi: 10.1128/SPECTRUM.00236-22.10.1128/SPECTRUM.00236-22PMC943124335867409Abdulrahman A., Mustafa F., AlAwadhi A.I., Alansari Q., AlAlawi B., AlQahtani M. Comparison of SARS-COV-2 nasal antigen test to nasopharyngeal RT-PCR in mildly symptomatic patients. MedRxiv. 2020 doi: 10.1101/2020.11.10.20228973.10.1101/2020.11.10.20228973Kawser Z., Hossain M., Suliman S., Lockman S., Gitaka J., Bandawe G., et al. An assessment of a rapid SARS-CoV-2 antigen test in Bangladesh. Am J Trop Med Hyg. 2022;107:845–849. doi: 10.4269/AJTMH.22-0068.10.4269/AJTMH.22-0068PMC965151635970285Kilic A., Hiestand B., Palavecino E. Evaluation of performance of the BD Veritor SARS-CoV-2 chromatographic immunoassay test in patients with symptoms of COVID-19. J Clin Microbiol. 2021;59 doi: 10.1128/JCM.00260-21. e00260–21.10.1128/JCM.00260-21PMC809185433637583Medoro A., Davinelli S., Voccola S., Cardinale G., Passarella D., Marziliano N., et al. Assessment of the diagnostic performance of a novel SARS-CoV-2 antigen sealing tube test strip (colloidal gold) as point-of-care surveillance test. Diagnostics (Basel) 2022;12:1279. doi: 10.3390/DIAGNOSTICS12051279.10.3390/DIAGNOSTICS12051279PMC914188735626434Pekosz A., Cooper C.K., Parvu V., Li M., Andrews J.C., Manabe Y.C., et al. Antigen-based testing but not real-time PCR correlates with SARS-CoV-2 virus culture. MedRxiv. 2020:2020. doi: 10.1101/2020.10.02.20205708.10.1101/2020.10.02.20205708Shin H., Lee S., Widyasari K., Yi J., Bae E., Kim S. Performance evaluation of STANDARD Q COVID-19 Ag home test for the diagnosis of COVID-19 during early symptom onset. J Clin Lab Anal. 2022;36 doi: 10.1002/JCLA.24410.10.1002/JCLA.24410PMC911095535441745Van Der Moeren N., Zwart V.F., Van Esch H.R.J.M., Stohr J.J.J.M., Pas S.D., Kluytmans J.A.J.W. Performance evaluation of a SARS-CoV-2 rapid antigen test: test performance in the community in The Netherlands. MedRxiv. 2020:2020. doi: 10.1101/2020.10.19.20215202.10.1101/2020.10.19.20215202Young S., Taylor S.N., Cammarata C.L., Varnado K.G., Roger-Dalbert C., Montano A., et al. Clinical evaluation of BD Veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the Sofia 2 SARS antigen point-of-care test. J Clin Microbiol. 2020;59 doi: 10.1128/JCM.02338-20. e02338–20.10.1128/JCM.02338-20PMC777145033023911Amer R.M., Samir M., Gaber O.A., EL-Deeb N.A., Abdelmoaty A.A., Ahmed A.A., et al. Diagnostic performance of rapid antigen test for COVID-19 and the effect of viral load, sampling time, subject’s clinical and laboratory parameters on test accuracy. J Infect Public Health. 2021;14:1446–1453. doi: 10.1016/J.JIPH.2021.06.002.10.1016/J.JIPH.2021.06.002PMC819226234175237Fatima A., Yaseen N., Fareed A., Samin K.A., Kanwal S., Qamar M. Role of COVID antigen in the diagnosis of COVID positive in obstetric patients. Pak J Med Health Sci. 2021;15:3356–3358. doi: 10.53350/PJMHS2115103356.10.53350/PJMHS2115103356Sicilia P., Castro G., Fantilli A.C., Gierotto R., López L., Barbás M.G., et al. Rapid screening of SARS-CoV-2 infection: good performance of nasopharyngeal and Nasal Mid-Turbinate swab for antigen detection among symptomatic and asymptomatic individuals. PLOS ONE. 2022;17 doi: 10.1371/JOURNAL.PONE.0266375.10.1371/JOURNAL.PONE.0266375PMC898632735363814Thell R., Kallab V., Weinhappel W., Mueckstein W., Heschl L., Heschl M., et al. Evaluation of a novel, rapid antigen detection test for the diagnosis of SARS-CoV-2. PLOS ONE. 2021;16 doi: 10.1371/JOURNAL.PONE.0259527.10.1371/JOURNAL.PONE.0259527PMC862925034843505Osterman A., Baldauf H.M., Eletreby M., Wettengel J.M., Afridi S.Q., Fuchs T., et al. Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting. Med Microbiol Immunol. 2021;210:65–72. doi: 10.1007/S00430-020-00698-8.10.1007/S00430-020-00698-8PMC781115633452927Sazed S.A., Kibria M.G., Hossain M.S., Zamil M.F., Adhikary P.C., Hossain M.E., et al. Clinical evaluation of a new antigen-based COVID-19 rapid diagnostic test from symptomatic patients. Diagnostics (Basel) 2021;11:2300. doi: 10.3390/DIAGNOSTICS11122300.10.3390/DIAGNOSTICS11122300PMC869994434943537Akashi Y., Horie M., Takeuchi Y., Togashi K., Adachi Y., Ueda A., et al. A prospective clinical evaluation of the diagnostic accuracy of the SARS-CoV-2 rapid antigen test using anterior nasal samples. J Infect Chemother. 2022;28:780–785. doi: 10.1016/J.JIAC.2022.02.016.10.1016/J.JIAC.2022.02.016PMC886608435256268Brihn A., Chang J., OYong K., Balter S., Terashita D., Rubin Z., et al. Diagnostic performance of an antigen test with RT-PCR for the detection of SARS-CoV-2 in a hospital setting – Los Angeles County, California, June-August 2020. MMWR Morb Mortal Wkly Rep. 2021;70:702–706. doi: 10.15585/MMWR.MM7019A3.10.15585/MMWR.MM7019A3PMC811815433983916Krüger L.J., Klein J.A.F., Tobian F., Gaeddert M., Lainati F., Klemm S., et al. Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDxTM: an antigen-detecting point-of-care device for SARS-CoV-2. Infection. 2022;50:395–406. doi: 10.1007/S15010-021-01681-Y.10.1007/S15010-021-01681-YPMC835890134383260Leli C., Di Matteo L., Gotta F., Cornaglia E., Vay D., Megna I., et al. Performance of a SARS-CoV-2 antigen rapid immunoassay in patients admitted to the emergency department. Int J Infect Dis. 2021;110:135–140. doi: 10.1016/J.IJID.2021.07.043.10.1016/J.IJID.2021.07.043PMC829506234302961Mitchell S.L., Orris S., Freeman T., Freeman M.C., Adam M., Axe M., et al. Performance of SARS-CoV-2 antigen testing in symptomatic and asymptomatic adults: a single-center evaluation. BMC Infect Dis. 2021;21:1071. doi: 10.1186/S12879-021-06716-1.10.1186/S12879-021-06716-1PMC852126334663212Schuit E., Venekamp R.P., Veldhuijzen I.K., van den Bijllaardt W., Pas S.D., Stohr J.J.J.M., et al. Head-to-head comparison of the accuracy of saliva and nasal rapid antigen SARS-CoV-2 self-testing: cross-sectional study. BMC Med. 2022;20:406. doi: 10.1186/S12916-022-02603-X.10.1186/S12916-022-02603-XPMC959038536280827Siddiqui Z.K., Chaudhary M., Robinson M.L., McCall A.B., Peralta R., Esteve R., et al. Implementation and accuracy of BinaxNOW rapid antigen COVID-19 test in asymptomatic and symptomatic populations in a high-volume self-referred testing site. Microbiol Spectr. 2021;9 doi: 10.1128/SPECTRUM.01008-21.10.1128/SPECTRUM.01008-21PMC866807834851137Van der Moeren N., Zwart V.F., Goderski G., Rijkers G.T., van den Bijllaardt W., Veenemans J., et al. Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL. J Clin Virol. 2021;141 doi: 10.1016/J.JCV.2021.104909.10.1016/J.JCV.2021.104909PMC826427334271540Agulló V., Fernández-González M., Ortiz de la Tabla V., Gonzalo-Jiménez N., García J.A., Masiá M., et al. Evaluation of the rapid antigen test PanBio COVID-19 in saliva and nasal swabs in a population-based point-of-care study. J Infect. 2021;82:186–230. doi: 10.1016/J.JINF.2020.12.007.10.1016/J.JINF.2020.12.007PMC772505133309541Almendares O., Prince-Guerra J.L., Nolen L.D., Gunn J.K.L., Dale A.P., Buono S.A., et al. Performance characteristics of the Abbott BinaxNOW SARS-CoV-2 antigen test in comparison to real-time reverse transcriptase PCR and viral culture in community testing sites during November 2020. J Clin Microbiol. 2022;60 doi: 10.1128/JCM.01742-21.10.1128/JCM.01742-21PMC876973334705535Drain P., Sulaiman R., Hoppers M., Lindner N.M., Lawson V., Ellis J.E. Performance of the LumiraDx microfluidic immunofluorescence point-of-care SARS-CoV-2 antigen test in asymptomatic adults and children. Am J Clin Pathol. 2022;157:602–607. doi: 10.1093/AJCP/AQAB173.10.1093/AJCP/AQAB173PMC897325634668536Martín-sánchez V., Fernández-villa T., Carvajal Urueña A., Rivero Rodríguez A., Reguero Celada S., Sánchez Antolín G., et al. Role of rapid antigen testing in population-based SARS-CoV-2 screening. J Clin Med. 2021;10:3854. doi: 10.3390/JCM10173854.10.3390/JCM10173854PMC843218734501297Nelson E.J., McKune S.L., Ryan K.A., Shapiro J., Mott-Young A.H., Myers P.D., et al. Antigen vs RT-PCR tests for screening quarantined students in Florida during the COVID-19 pandemic SARS-CoV-2 Delta variant surge. JAMA Pediatr. 2022;176:525–526. doi: 10.1001/JAMAPEDIATRICS.2022.0080.10.1001/JAMAPEDIATRICS.2022.0080PMC890268935254393Peacock W.F., Soto-Ruiz K.M., House S.L., Cannon C.M., Headden G., Tiffany B., et al. Utility of COVID-19 antigen testing in the emergency department. J Am Coll Emerg Physicians Open. 2022;3 doi: 10.1002/EMP2.12605.10.1002/EMP2.12605PMC876095235072154Schuit E., Veldhuijzen I.K., Venekamp R.P., Van Den Bijllaardt W., Pas S.D., Lodder E.B., et al. Diagnostic accuracy of rapid antigen tests in asymptomatic and presymptomatic close contacts of individuals with confirmed SARS-CoV-2 infection: cross sectional study. BMJ. 2021;374:n1676. doi: 10.1136/BMJ.N1676.10.1136/BMJ.N1676PMC831414534315770Tinker S.C., Szablewski C.M., Litvintseva A.P., Drenzek C., Voccio G.E., Hunter M.A., et al. Point-of-care antigen test for SARS-CoV-2 in asymptomatic college students. Emerg Infect Dis. 2021;27:2662–2665. doi: 10.3201/EID2710.210080.10.3201/EID2710.210080PMC846230934399086Torres I., Poujois S., Albert E., Colomina J., Navarro D. Evaluation of a rapid antigen test (PanBioTM COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients. Clin Microbiol Infect. 2021;27:636.e1–636.e4. doi: 10.1016/J.CMI.2020.12.022.10.1016/J.CMI.2020.12.022PMC783384333421573Aranaz-Andrés J.M., Chávez A.C.F., Laso A.M.G., Abreu M., Núñez P.M., Galán J.C., et al. Analysis of the diagnostic accuracy of rapid antigenic tests for detection of SARS-CoV-2 in hospital outbreak situation. Eur J Clin Microbiol Infect Dis. 2022;41:305–312. doi: 10.1007/S10096-021-04346-8.10.1007/S10096-021-04346-8PMC860049134792699Barnacle J.R., Houston H., Baltas I., Takata J., Kavallieros K., Vaughan N., et al. Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions. J Hosp Infect. 2022;123:92–99. doi: 10.1016/J.JHIN.2022.02.010.10.1016/J.JHIN.2022.02.010PMC886395635217130Caruana G., Lebrun L.L., Aebischer O., Opota O., Urbano L., de Rham M., et al. The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients. New Microbe. New Infect. 2021;42 doi: 10.1016/J.NMNI.2021.100899.10.1016/J.NMNI.2021.100899PMC811929234007453Demuth S., Damaschek S., Schildgen O., Schildgen V. Low sensitivity of SARS-CoV-2 rapid antigen self-tests under laboratory conditions. New Microbe New Infect. 2021;43 doi: 10.1016/J.NMNI.2021.100916.10.1016/J.NMNI.2021.100916PMC827656534277011Ferguson J., Dunn S., Best A., Mirza J., Percival B., Mayhew M., et al. Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: testing frequency and public health messaging is key. PLOS Biol. 2021;19 doi: 10.1371/JOURNAL.PBIO.3001216.10.1371/JOURNAL.PBIO.3001216PMC811264333914730Fernandez-Montero A., Argemi J., Rodríguez J.A., Ariño A.H., Moreno-Galarraga L. Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values. EClinicalMedicine. 2021;37 doi: 10.1016/J.ECLINM.2021.100954.10.1016/J.ECLINM.2021.100954PMC818954134127960Finch L.S., Harris A., Lester C., Veal D., Jones K., Fulton J., et al. Implementation study of SARS-CoV-2 antigen lateral flow tests in men’s professional (Premiership) rugby union sports squads in England during the COVID-19 pandemic. J Infect. 2022;84 doi: 10.1016/J.JINF.2021.12.037. e3–5.10.1016/J.JINF.2021.12.037PMC871770934974058Garciá-Fiñana M., Hughes D.M., Cheyne C.P., Burnside G., Stockbridge M., Fowler T.A., et al. Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study. BMJ. 2021;374:n1637. doi: 10.1136/BMJ.N1637.10.1136/BMJ.N1637PMC825945534230058Kumar K., Sampritha U., Maganty V., Prakash A., Basumatary J., Adappa K., et al. Pre-operative SARS CoV-2 rapid antigen test and reverse transcription polymerase chain reaction: a conundrum in surgical decision making. Indian J Ophthalmol. 2021;69:1560–1562. doi: 10.4103/IJO.IJO_430_21.10.4103/IJO.IJO_430_21PMC830231334011741Mungomklang A., Trichaisri N., Jirachewee J., Sukprasert J., Tulalamba W., Viprakasit V. Limited sensitivity of a rapid SARS-CoV-2 antigen detection assay for surveillance of asymptomatic individuals in Thailand. Am J Trop Med Hyg. 2021;105:1505–1509. doi: 10.4269/AJTMH.21-0809.10.4269/AJTMH.21-0809PMC864133034634778Okoye N.C., Barker A.P., Curtis K., Orlandi R.R., Snavely E.A., Wright C., et al. Performance characteristics of BinaxNOW COVID-19 antigen card for screening asymptomatic individuals in a university setting. J Clin Microbiol. 2021;59 doi: 10.1128/JCM.03282-20. e03282–20.10.1128/JCM.03282-20PMC809274033509809Qahtani M.A., Yang C.W.T., Lazosky L., Li X., D’cruz J., Romney M.G., et al. SARS-CoV-2 rapid antigen testing for departing passengers at Vancouver International Airport. J Travel Med. 2021;28:taab085. doi: 10.1093/JTM/TAAB085.10.1093/JTM/TAAB085PMC819461434046663Shrestha B., Neupane A.K., Pant S., Shrestha A., Bastola A., Rajbhandari B., et al. Sensitivity and specificity of lateral flow antigen test kits for COVID-19 in asymptomatic population of quarantine centre of province 3. Kathmandu Univ Med J (KUMJ) 2020;18:36–39.33605236Šterbenc A., Tomič V., Bidovec Stojković U., Vrankar K., Rozman A., Zidarn M. Usefulness of rapid antigen testing for SARS-CoV-2 screening of healthcare workers: a pilot study. Clin Exp Med. 2022;22:157–160. doi: 10.1007/S10238-021-00722-Y.10.1007/S10238-021-00722-YPMC814030834021827Thakur P., Saxena S., Manchanda V., Rana N., Goel R., Arora R. Utility of antigen-based rapid diagnostic test for detection of SARS-CoV-2 virus in routine hospital settings. Lab Med. 2021;52:e154–e158. doi: 10.1093/LABMED/LMAB033.10.1093/LABMED/LMAB033PMC813547033928384Visci G., Zunarelli C., Violante F., Boffetta P. Application of SARS-CoV-2 antigenic test in asymptomatic workers: sensitivity and specificity of the test. Med Lav. 2021;112:340–345. doi: 10.23749/MDL.V112I5.12097.10.23749/MDL.V112I5.12097PMC860057634726662Baro B., Rodo P., Ouchi D., Bordoy A.E., Saya Amaro E.N., Salsench S.V., et al. Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison. J Infect. 2021;82:269–275. doi: 10.1016/J.JINF.2021.04.009.10.1016/J.JINF.2021.04.009PMC805340333882299Guo C., Yao L., Chen F., Zhang C., Chen W. Development and performance verification of colloidal gold labeled SARS-CoV-2 antigen detection method for routine popular screening of COVID-19 with clinical samples in Poland and China. MedRxiv. 2021:2021. doi: 10.1101/2021.11.22.21266719.10.1101/2021.11.22.21266719Patriquin G., LeBlanc J.J., Williams C., Hatchette T.F., Ross J., Barrett L., et al. Comparison between nasal and nasopharyngeal swabs for SARS-CoV-2 rapid antigen detection in an asymptomatic population, and direct confirmation by RT-PCR from the residual buffer. Microbiol Spectr. 2022;10 doi: 10.1128/SPECTRUM.02455-21.10.1128/SPECTRUM.02455-21PMC884909535171010Pilecky M., Harm S., Bauer C., Zottl J., Emprechtinger R., Eichhorn T., et al. Performance of lateral flow assays for SARS-CoV-2 compared to RT-qPCR. J Infect. 2022;84:579–613. doi: 10.1016/J.JINF.2022.01.013.10.1016/J.JINF.2022.01.013PMC875820035033581Rottenstreich A., Zarbiv G., Kabiri D., Porat S., Sompolinsky Y., Reubinoff B., et al. Rapid antigen detection testing for universal screening for severe acute respiratory syndrome coronavirus 2 in women admitted for delivery. Am J Obstet Gynecol. 2021;224:539–540. doi: 10.1016/J.AJOG.2021.01.002.10.1016/J.AJOG.2021.01.002PMC783713333453181Tauh T., Lee S.M., Meyler P., Mozel M., McLennan M., Hoang L.M.N. Diagnostic performance and clinical application of preoperative COVID-19 bedside testing with ID NOWTM. Can J Anaesth. 2021;68:1569–1571. doi: 10.1007/S12630-021-02035-W.10.1007/S12630-021-02035-WPMC813954334021477Prince-Guerra JL, Almendares O, Nolen LD, Gunn JKL, Dale AP, Buono SA, et al. Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites - Pima County, Arizona, November 3-17, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70:100-105. 10.15585/mmwr.mm7003e3.10.15585/mmwr.mm7003e3PMC782176633476316Beck E.T., Paar W., Fojut L., Serwe J., Jahnke R.R. Comparison of the Quidel sofia SARS FIA test to the Hologic aptima SARS-CoV-2 TMA test for diagnosis of COVID-19 in symptomatic outpatients. J Clin Microbiol. 2021;59 doi: 10.1128/jcm.02727-20.10.1128/jcm.02727-20PMC811114833239376Domínguez Fernández M, Seoane Estévez A, Lamelo Alfonsín F, Bou G. Usefulness of the Lumiradx™ SARS-COV-2 antigen test in nursing home. Enferm Infecc Microbiol Clin (Engl Ed). 2022 Aug-Sep;40:404-405. 10.1016/j.eimce.2022.04.008.10.1016/j.eimce.2022.04.008PMC907834635537994Turcato G., Zaboli A., Pfeifer N., Ciccariello L., Sibilio S., Tezza G., et al. Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: A preliminary report. J Infect. 2021;82:e14–e16. doi: 10.1016/j.jinf.2020.12.012.10.1016/j.jinf.2020.12.012PMC774897533347944
trying2...
trying...
trying2...
Update of European Society of Clinical Microbiology and Infectious Diseases coronavirus disease 2019 guidelines: diagnostic testing for severe acute respiratory syndrome coronavirus 2. | LitMetric

Update of European Society of Clinical Microbiology and Infectious Diseases coronavirus disease 2019 guidelines: diagnostic testing for severe acute respiratory syndrome coronavirus 2.

Clin Microbiol Infect

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Greece; Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Centre (UGMLC), Philipps University Marburg, German Centre for Lung Research (DZL), Marburg, Germany. Electronic address:

Published: July 2023

Scope: Since the onset of COVID-19, several assays have been deployed for the diagnosis of SARS-CoV-2. The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) published the first set of guidelines on SARS-CoV-2 in vitro diagnosis in February 2022. Because the COVID-19 landscape is rapidly evolving, the relevant ESCMID guidelines panel releases an update of the previously published recommendations on diagnostic testing for SARS-CoV-2. This update aims to delineate the best diagnostic approach for SARS-CoV-2 in different populations based on current evidence.

Methods: An ESCMID COVID-19 guidelines task force was established by the ESCMID Executive Committee. A small group was established, half appointed by the chair, and the remaining selected with an open call. The panel met virtually once a week. For all decisions, a simple majority vote was used. A list of clinical questions using the population, intervention, comparison, and outcome (PICO) format was developed at the beginning of the process. For each PICO, 2 panel members performed a literature search focusing on systematic reviews with a third panellist involved in case of inconsistent results. The panel reassessed the PICOs previously defined as priority in the first set of guidelines and decided to address 49 PICO questions, because 6 of them were discarded as outdated/non-clinically relevant. The 'Grading of Recommendations Assessment, Development and Evaluation (GRADE)-adoption, adaptation, and de novo development of recommendations (ADOLOPMENT)' evidence-to-decision framework was used to produce the guidelines.

Questions Addressed By The Guidelines And Recommendations: After literature search, we updated 16 PICO questions; these PICOs address the use of antigen-based assays among symptomatic and asymptomatic patients with different ages, COVID-19 severity status or risk for severe COVID-19, time since the onset of symptoms/contact with an infectious case, and finally, types of biomaterials used.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122552PMC
http://dx.doi.org/10.1016/j.cmi.2023.04.019DOI Listing

Publication Analysis

Top Keywords

european society
8
society clinical
8
clinical microbiology
8
microbiology infectious
8
infectious diseases
8
diagnostic testing
8
set guidelines
8
literature search
8
pico questions
8
guidelines
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!